Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 suPAR is the circulating factor in some but not all FSGS.

Literature DB >> 25157837

suPAR is the circulating factor in some but not all FSGS.

Howard Trachtman¹, Jochen Reiser².

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2014 PMID： 25157837 DOI： 10.1038/nrneph.2014.113-c1

Source DB: PubMed Journal: Nat Rev Nephrol ISSN： 1759-5061 Impact factor: 28.314

× No keyword cloud information.

11 in total

1. Glomerular disease: The search goes on: suPAR is not the elusive FSGS factor.

Authors: Jeroen K Deegens; Jack F Wetzels
Journal: Nat Rev Nephrol Date: 2014-06-24 Impact factor: 28.314

2. Are serum suPAR determinations by current ELISA methodology reliable diagnostic biomarkers for FSGS?

Authors: Detlef Schlöndorff
Journal: Kidney Int Date: 2014-03 Impact factor: 10.612

3. Serum suPAR concentrations in patients with focal segmental glomerulosclerosis with end-stage renal disease.

Authors: Rutger J H Maas; Jack F M Wetzels; Jeroen K J Deegens
Journal: Kidney Int Date: 2014-03 Impact factor: 10.612

4. Soluble urokinase-type plasminogen activator receptor in FSGS: stirred but not shaken.

Authors: Jochen Reiser; Harold Chapman
Journal: J Am Soc Nephrol Date: 2014-05-01 Impact factor: 10.121

5. Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease.

Authors: Björn Meijers; Ruben Poesen; Kathleen Claes; Ruth Dietrich; Bert Bammens; Ben Sprangers; Maarten Naesens; Markus Storr; Dirk Kuypers; Pieter Evenepoel
Journal: Kidney Int Date: 2014-06-04 Impact factor: 10.612

6. Administration of recombinant soluble urokinase receptor per se is not sufficient to induce podocyte alterations and proteinuria in mice.

Authors: Dominique Cathelin; Sandrine Placier; Michael Ploug; Marie-Christine Verpont; Sophie Vandermeersch; Yosu Luque; Alexandre Hertig; Eric Rondeau; Laurent Mesnard
Journal: J Am Soc Nephrol Date: 2014-05-01 Impact factor: 10.121

7. Urine soluble urokinase-type plasminogen activator receptor levels correlate with proteinuria in Puumala hantavirus infection.

Authors: T K Outinen; S Mäkelä; R Huttunen; N Mäenpää; D Libraty; A Vaheri; J Mustonen; J Aittoniemi
Journal: J Intern Med Date: 2014-05-14 Impact factor: 8.989

Review 8. Pathobiology of focal segmental glomerulosclerosis: new developments.

Authors: Vivette D D'Agati
Journal: Curr Opin Nephrol Hypertens Date: 2012-05 Impact factor: 2.894

9. Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.

Authors: Nada Alachkar; Changli Wei; Lois J Arend; Annette M Jackson; Lorraine C Racusen; Alessia Fornoni; George Burke; Hamid Rabb; Kavita Kakkad; Jochen Reiser; Michelle M Estrella
Journal: Transplantation Date: 2013-10-15 Impact factor: 4.939

10. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.

Authors: S Theilade; S Lyngbaek; T W Hansen; J Eugen-Olsen; M Fenger; P Rossing; J L Jeppesen
Journal: J Intern Med Date: 2014-06-23 Impact factor: 8.989

3 in total